Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Tadasu Sakai"'
Publikováno v:
Clinical and Experimental Nephrology. 12:28-32
Many chronic renal diseases in children, including membranoproliferative glomerulonephritis (MPGN), often continue into adulthood, and these patients require continuing management. Despite the importance of the topic, there has been limited discussio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb9f707aa1a89b9234aae09f6806380f
https://doi.org/10.1007/s10157-007-0014-5
https://doi.org/10.1007/s10157-007-0014-5
Publikováno v:
Nihon Shoni Jinzobyo Gakkai Zasshi. 20:105-110
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::854c594fc6b649e76e6170c002e9d5f0
https://doi.org/10.3165/jjpn.20.105
https://doi.org/10.3165/jjpn.20.105
Autor:
Masataka Hisano, Yoshifusa Abe, Yuichirou Tsuji, Kazuo Itabashi, Tadasu Sakai, Izumi Ichihashi, Ichirou Kobayashi
Publikováno v:
The Showa University Journal of Medical Sciences. 18:103-108
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8524ebc29207329d92af0acfb2be0999
https://doi.org/10.15369/sujms1989.18.103
https://doi.org/10.15369/sujms1989.18.103
Publikováno v:
Pediatric Nephrology. 18:1000-1004
Eight patients with focal segmental membranoproliferative glomerulonephritis (FSMPGN) were followed for 5-16 years. Their urinary abnormalities were detected by school urinary screening in seven, and one patient presented with nephrotic syndrome. All
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c71020878625d583754c19b641447312
https://doi.org/10.1007/s00467-003-1231-0
https://doi.org/10.1007/s00467-003-1231-0
Autor:
Kikuo Iitaka, Naomi Iwasaki, Shinya Nakamura, Hiroe Koshino, Shunsuke Moriya, Tadasu Sakai, Osamu Motoyama
Publikováno v:
Clinical and Experimental Nephrology. 7:58-62
We report the long-term follow-up of two patients with type II membranoproliferative glomerulonephritis (MPGN). One Patients was treated with high-dose alternate-day prednisolone and the other with dipyridamole. Both had favorable clinical courses ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::104432e9f6a8f5e1c39c760276d712a3
https://doi.org/10.1007/s101570300008
https://doi.org/10.1007/s101570300008
Autor:
Kazunari Yoshida, Toru Takemura, Tadao Endo, Tadasu Sakai, Takayasu Taira, Sumiko Yamamoto, Toyoaki Uchida, Hideo Hidai, Yoshinori Taoka, Hidetoshi Kuruma, Tetsuo Chiba, Kyoko Watanabe, Toru Hyodo, Shiro Baba, Katsuharu Takekawa, Takanori Tojyo, Satoru Shimura
Publikováno v:
Nihon Toseki Igakkai Zasshi. 36:1719-1723
SARSは38度以上の発熱で発症し病初期にはインフルエンザと鑑別困難である. SARSとインフルエンザとの鑑別に有用な知見を得る目的で, 2002年11月から2003年3月期における血液透析患者に対す
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::addfc5e7dab82e349b4d217ec0fa4e40
https://doi.org/10.4009/jsdt.36.1719
https://doi.org/10.4009/jsdt.36.1719
Publikováno v:
Pediatric Nephrology. 17:373-378
Seven patients with type III membranoproliferative glomerulonephritis (MPGN) were followed for 9-17 years. Their mean age at presentation was 11.0 years. Their urinary abnormalities were detected by school urinary screening in five, and two patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b356e6baa1fb300b79a63022bc386a53
https://doi.org/10.1007/s00467-001-0781-2
https://doi.org/10.1007/s00467-001-0781-2
Autor:
Hiroshi Chikaoka, Yuichirou Tsuji, Masataka Hisano, Yoshifusa Abe, Tadasu Sakai, Takaaki Takayanagi, Yoji Iikura
Publikováno v:
Nihon Shoni Jinzobyo Gakkai Zasshi. 15:29-32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e80c9e6ffd604f1a499a0cc30f2cf14
https://doi.org/10.3165/jjpn.15.29
https://doi.org/10.3165/jjpn.15.29
Autor:
Tadao Endo, Hideo Hidai, Tadasu Sakai, Toyoaki Uchida, Natsuko Gushiken, Toyoko Oyama, Sumiko Yamamoto, Miki Sugimoto, Toru Hyodo, Takayasu Taira, Kazunari Yoshida, Shiro Baba, Tetsuo Chiba
Publikováno v:
Nihon Toseki Igakkai Zasshi. 34:119-124
血液透析患者20人を対象とし腸溶性マイクロカプセルビフィズス菌製剤を服用させその有用性を検討するために, PCR (protein catabolic rate), Kt/V, TACBUN (time averaged concentration of blood urea nitrogen) 等
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f31a283ca2ac9ec9fe7db57fdabce701
https://doi.org/10.4009/jsdt.34.119
https://doi.org/10.4009/jsdt.34.119
Autor:
Takayasu Taira, Toru Hyodo, Tadasu Sakai, Kazunari Yoshida, Sumiko Yamamoto, Tadao Endo, Shiro Baba, Toyoaki Uchida
Publikováno v:
Nihon Toseki Igakkai Zasshi. 34:1421-1426
今回, 我々は血液透析患者の勃起機能を評価し, また, クエン酸シルデナフィルの投与を試みた. さらに2001年1月1日現在での世界における透析患者に対するクエン酸シルデナフィル投与の
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed1bfb1e0a03071e7ac252b3e968270d
https://doi.org/10.4009/jsdt.34.1421
https://doi.org/10.4009/jsdt.34.1421